Review by AMA as industry ethics queried

The guild came under fire last week for its endorsement of a weight loss program based on a genetic test offered by Melbourne company MyGene, reported by MO earlier this year (MO online, 12 April).

The controversy followed recent criticism of payments from Pfizer to pharmacists who enrolled patients in medication compliance support programs, and of a guild deal with Blackmores involving prompts in dispensing software reminding pharmacists to recommend complementary medicines.

AMA president Dr Steve Hambleton said the kind of “minor hospitality” GPs might occasionally receive from industry at educational events was not something they would be required to disclose but he had referred the issue to the ethics committee for more guidance.

Activist and academic Dr Ken Harvey said it was important for GPs to have a good working relationship with industry, but they should make that relationship clear to patients.

Monash Centre for

Latest

Trending